Real-world Use of Carfilzomib Among Multiple Myeloma Patients in Europe

Clinical trial NCT03091127 · COMPLETED

Trial details

NCT number: NCT03091127
Sponsor: Amgen
Status: COMPLETED
Study type: OBSERVATIONAL

Multiple Myeloma

Start date: 2017-03-14
Primary completion: 2020-03-17
Enrollment: 705

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.